Get started
111

NANG KUANG PHARMACEUTICAL CO

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

1752 chart


Full chart

1752 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.36 B‬ TWD
Dividend yield (indicated)
4.63%
Price to earnings Ratio (TTM)
35.70
Basic EPS (TTM)
1.20 TWD
Net income (FY)
‪198.41 M‬ TWD
Revenue (FY)
‪2.15 B‬ TWD
Shares float
‪80.97 M‬
Beta (1Y)
0.52

About NANG KUANG PHARMACEUTICAL CO


Sector
Health Technology
CEO
Yue Pei Wang
Headquarters
Tainan
Website
nangkuang.com.tw
Founded
1963
ISIN
TW0001752004
FIGI
BBG0015S6MF9
Nang Kuang Pharmaceutical Co., Ltd. engages in the manufacture, process, and sale of western medicine and medical equipment. It specializes in eye drops, antibiotics, lozenges, solutions, powders, ointments, icing, citric acid, granules, sterile injection, gel, film-coated ingots, irrigation fluid, enteric-coated tablets, and frozen crystal injection. Its products include large volume parenterals, aseptic parenterals, lyophilized injection, pre-filled syringe, pre-mixed IV infusion bags, and oral suspensions. Nang Kuang Pharmaceutical was founded in February 1963 and is headquartered in Tainan, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

1752 news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 1752 is 43.20 TWD — it has increased by 0.12% in the past 24 hours. Watch NANG KUANG PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange NANG KUANG PHARMACEUTICAL CO stocks are traded under the ticker 1752.
1752 stock has risen by 0.58% compared to the previous week, the month change is a −0.46% fall, over the last year NANG KUANG PHARMACEUTICAL CO has showed a −18.18% decrease.
1752 reached its all-time high on Apr 28, 2023 with the price of 85.70 TWD, and its all-time low was 32.60 TWD and was reached on Oct 25, 2022. View more price dynamics on 1752 chart.
See other stocks reaching their highest and lowest prices.
1752 stock is 1.74% volatile and has beta coefficient of 0.52. Track NANG KUANG PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is NANG KUANG PHARMACEUTICAL CO there?
Today NANG KUANG PHARMACEUTICAL CO has the market capitalization of ‪4.36 B‬, it has increased by 1.41% over the last week.
Yes, you can track NANG KUANG PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
NANG KUANG PHARMACEUTICAL CO is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
1752 net income for the last quarter is ‪58.11 M‬ TWD, while the quarter before that showed ‪44.13 M‬ TWD of net income which accounts for 31.67% change. Track more NANG KUANG PHARMACEUTICAL CO financial stats to get the full picture.
NANG KUANG PHARMACEUTICAL CO dividend yield was 3.75% in 2023, and payout ratio reached 101.80%. The year before the numbers were 3.60% and 65.99% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NANG KUANG PHARMACEUTICAL CO EBITDA is ‪387.55 M‬ TWD, and current EBITDA margin is 20.54%. See more stats in NANG KUANG PHARMACEUTICAL CO financial statements.
Like other stocks, 1752 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANG KUANG PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NANG KUANG PHARMACEUTICAL CO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NANG KUANG PHARMACEUTICAL CO stock shows the sell signal. See more of NANG KUANG PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.